RBA Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.72M Buy
54,528
+1
+0% +$96 1.7% 31
2025
Q4
$5.24M Buy
54,527
+197
+0.4% +$19.1K 1.77% 24
2025
Q3
$5.17M Buy
54,330
+976
+2% +$89.7K 1.79% 27
2025
Q2
$4.65M Buy
53,354
+683
+1% +$57.9K 1.73% 26
2025
Q1
$4.73M Buy
52,671
+2,131
+4% +$191K 1.87% 24
2024
Q4
$4.04M Buy
50,540
+1,045
+2% +$90.5K 1.54% 36
2024
Q3
$4.46M Buy
49,495
+5,429
+12% +$457K 1.72% 28
2024
Q2
$3.47M Buy
44,066
+613
+1% +$50.3K 1.39% 39
2024
Q1
$3.79M Buy
43,453
+933
+2% +$79.6K 1.53% 32
2023
Q4
$3.5M Buy
42,520
+330
+0.8% +$25.2K 1.53% 35
2023
Q3
$3.31M Buy
42,190
+779
+2% +$65.2K 1.59% 33
2023
Q2
$3.65M Buy
41,411
+749
+2% +$64.5K 1.7% 31
2023
Q1
$3.28M Buy
40,662
+2,027
+5% +$165K 1.63% 33
2022
Q4
$3M Sell
38,635
-117
-0.3% -$9.48K 1.57% 33
2022
Q3
$3.13M Buy
38,752
+616
+2% +$55.4K 1.8% 28
2022
Q2
$3.42M Buy
38,136
+660
+2% +$66.9K 1.9% 24
2022
Q1
$4.16M Buy
37,476
+17,129
+84% +$1.81M 2% 18
2021
Q4
$2.1M Buy
+20,347
New +$2.36M 0.99% 44
2021
Q2
Sell
-16,369
Closed -$1.93M 188
2021
Q1
$1.93M Buy
16,369
+726
+5% +$85.1K 1.64% 26
2020
Q4
$1.83M Buy
15,643
+1,359
+10% +$150K 1.1% 40
2020
Q3
$1.48M Buy
14,284
+4,740
+50% +$476K 1% 42
2020
Q2
$875K Buy
9,544
+2,916
+44% +$280K 0.64% 59
2020
Q1
$598K Buy
6,628
+3,534
+114% +$376K 0.52% 61
2019
Q4
$350K Buy
3,094
+8
+0.3% +$878 0.24% 81
2019
Q3
$335K Sell
3,086
-12
-0.4% -$1.25K 0.26% 73
2019
Q2
$302K Buy
3,098
+839
+37% +$76.6K 0.23% 69
2019
Q1
$200K Buy
+2,259
New +$202K 0.16% 79

Other funds holding MDT

RBA Wealth Management's MDT Position: Q1 2026 in Review

RBA Wealth Management increased its Medtronic (MDT) stake by 0% in Q1 2026, buying an estimated $96 and bringing the position to 54,528 shares worth $4.72M. The position accounts for 1.7% of the portfolio, ranked #31.

RBA Wealth Management first reported a position in MDT in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.24M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • RBA Wealth Management held 54,528 shares of Medtronic worth $4.72M as of Q1 2026.
  • RBA Wealth Management bought 1 Medtronic share in Q1 2026, an estimated $96.
  • Medtronic made up 1.7% of RBA Wealth Management's portfolio in Q1 2026, its #31 holding.
  • RBA Wealth Management first reported a position in Medtronic in Q1 2019 and has held it in 27 quarters since.
  • RBA Wealth Management's Medtronic position peaked at $5.24M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on RBA Wealth Management's 13F filing for Q1 2026, filed 23 Apr 2026.